BMAC for Temporomandibular Joint Disorder

This trial tests a new treatment using Bone Marrow Aspirate Concentrate (BMAC) for individuals with temporomandibular joint disorder (TMJ pain) that hasn't improved with other treatments. Researchers aim to determine if BMAC injections during TMJ surgery can reduce inflammation and damage compared to the usual corticosteroid (CS) injections. Participants will be randomly assigned to receive either BMAC or steroids during their procedure. Suitable candidates for this trial should have ongoing TMJ pain and dysfunction despite trying treatments like pain relievers or physical therapy for at least 30 days. As a Phase 3 trial, this study represents the final step before FDA approval, offering a chance to contribute to potentially groundbreaking treatment advancements.

The trial information does not specify if you need to stop taking your current medications. However, since the trial involves comparing BMAC to corticosteroid injections, it's possible that some medications might need to be adjusted. Please consult with the trial coordinators for specific guidance.

Research has shown that Bone Marrow Aspirate Concentrate (BMAC) is usually well-tolerated for joint issues. One study found that BMAC injections improved symptoms of temporomandibular joint (TMJ) disorders without causing major side effects. Another study demonstrated that a single BMAC injection was safe and improved knee osteoarthritis, suggesting it might also be safe for other joints like the TMJ. BMAC aims to ease symptoms and help repair joint tissues. While these results are encouraging, they rely on previous studies. Participants should consider this information when deciding whether to join the trial.¹²³⁴⁵

Researchers are excited about the use of Bone Marrow Aspirate Concentrate (BMAC) for treating Temporomandibular Joint (TMJ) Disorder because it introduces a regenerative approach to healing. Unlike standard treatments like corticosteroid injections that focus mainly on reducing inflammation and pain, BMAC is derived from the patient's own bone marrow and contains cells that have the potential to repair and regenerate joint tissues. This could mean longer-lasting relief and improved joint function compared to current options. By harnessing the body's natural healing processes, BMAC offers a promising alternative for patients suffering from TMJ disorders.

Research suggests that Bone Marrow Aspirate Concentrate (BMAC) may help treat jaw joint disorders. In this trial, participants in the BMAC arm will receive BMAC injections during their TMJ arthroscopy procedure. Studies have shown that BMAC can repair damage from jaw joint arthritis, leading to improved jaw movement and reduced pain. In one study, patients who received BMAC injections reported greater improvement in jaw function and pain relief than those who did not. Another study found that individuals with jaw joint disorders experienced better outcomes after receiving BMAC injections. While these findings are encouraging, further research is needed to confirm its effectiveness in larger groups.²³⁵⁶⁷